DEPARTMENT OF RADIATION ONCOLOGY

Rohilkhand Cancer Institute is one of the Premiere centres of radiation oncology established in the city of Bareilly, Uttar Pradesh, India. The institute was started with the intention of providing patients with State-of-the-art radiotherapy facilities of international standards with comprehensive cancer care at affordable, nominal charges. Radiotherapy is a highly effective form of cancer treatment with a wide range of uses and applications. Radiation therapy helps to completely cure cancer either as a single modality or along with other treatments for relieving symptoms or extending the overall survival in patients with highly advanced or metastatic cancers. Radiation therapy targets the affected area with high-energy beams, often to the location of the tumour or the area where a tumour was removed after surgery to destroy any remaining microscopic cancer cells. Radiotherapy contributes to cancer cures worldwide as well as improving the quality of life for many others.

Our Team

Dr. Laxman Pandey
MBBS, MD (Radiotherapy)

Dr. Laxman Pandey is a Consultant Radiation Oncologist and completed his MD Radiotherapy from Sarojini Naidu Medical College Agra in 2017. He has five years of experience and counting in radiotherapy in various institutes including the MMIMSR Ambala, AIIMS -Rishikesh, and SRMS Bareilly. His clinical expertise is Conformal radiation therapy (SRT/SBRT/IGRT/IMRT/VMAT), Brachytherapy, Chemotherapy for solid tumours and Palliative care. Currently, he is associated with Rohilkhand Cancer Institute Bareilly as Assistant Professor and Head- Department of Radiation Oncology. He is also an active member of the Association of Radiation Oncologists of India (AROI), and the European Society for Medical Oncology (ESMO) and had valuable publications in both national and international journals.

Dr. Laxman Pandey – Research And Publication

1: Joseph D, Pandey L, Pasricha R, Raut S, Yanpothung Y, Ibrahim A, et al. Stage migration in head and neck cancers due to extranodal extension: Clinical experience from a tertiary care centre. J Med Evid 2021. More.

2: Pandey, R. Pasricha, D. Joseph et al., Use of complementary and alternative medicine among patients with cancer in a sub-Himalayan state in India: An exploratory study. Journal of Ayurveda and Integrative Medicine 12 (2021) 126-130. More.

3: Inampudi P, Seam RK, Pandey L, Malik D, Pandey A, Anjali A, et al. 84P Prospective comparative study of dosimetric parameters and acute radiation toxicity of 3-dimensional conformal radiotherapy (3DCRT) and volumetric modulated arc therapy (VMAT) in post-mastectomy carcinoma breast patients. Ann Oncol. 2021;32: S57 More.

4: A. Pandey, R.K. Seam, L. Pandey, D. Malik, R. Mahajan, et al. Adaptive radiotherapy in head and neck cancer: A prospective dominatrices and volumetric study. Ann Oncol. 202;32: S794 More.

Work experience

M.D. Radiation oncology from Institute of medical sciences, B.H.U. , VaranasiWorked as senior resident in Department of Radiation Oncology, PGIMER, ChandigarhAbout 3 years of experience in the field of Radiation Oncology (Post MD) practising all Radiotherapy techniques like conventional, 3DCRT, IMRT, IGRT, SRS, SBRT and brachytherapy in almost all cancer sitesTotal 6 years of experience in the field of Oncology.

Memberships

  • Association of radiation oncologist of india (AROI)
  • European Society for Medical Oncology (ESMO)
  • The International Association for the Study of Lung Cancer (IASCL)

Awards

2nd prize in the poster presentation in the annual conference of oncology forum 20203rd prize in oral presentation in UPAROICON, 2022.

Special interests

Head and neck cancers, gastric cancers, brain tumours, cervical cancer, lung cancer, breast cancer, bladder cancer and  oesophagal cancer.

Dr. Ankita Pandey

Publications:

  1. Mishra R, Singh S, Patel G, Mandal A, Mishra H, Pandey A, Bahadur B, Singh P, Sachan S, Tewari M (2024) Comparative analysis of simultaneous integrated boost and sequential boost radiotherapy in node-positive cervical cancer: dosimetric and radiobiological considerations. Radiat Environ Biophys 63:297–306. https://doi.org/10.1007/s00411-024-01069-0
  2. Pandey A, Patel GK, Singh S (2024) Impact of Unplanned Treatment Gaps and Dose Rate Effect on Survival During Radiotherapy in Breast Cancer ( BRIDGE study ). 9:214–223
  3. Mishra H, Pandey A, Mishra R, et al (2023) Evaluation of Late Toxicities in Postoperative Cases of Oral Cavity Cancer Treated by Intensity-Modulated Radiotherapy (IMRT): A Retrospective Cohort Study. J Clin Diagnostic Res 1–5. https://doi.org/10.7860/jcdr/2023/65916.18550
  4. Mishra H, Singh S, Mishra R, Pandey A, Mandal A, Prakash E, Patel G, Shah M, Singh T(2023) Evaluation of survival outcome and prognostic factors for oral cavity cancer treated with volumetric arc therapy. J Cancer Res Clin Oncol 149:16983–16992. https://doi.org/10.1007/s00432-023-05397-4
  5. Pandey A (2024) Radiotherapy in Hepatocellular Carcinoma – A Review of Literature. 13:300–304
  6. Prashar P, Thakur V, Bhardwaj BB, Thakur A, Pandey A, Sharma H (2023) Probing Prostate Awareness : A Comprehensive Study on Knowledge , Risks , and Prevention in District Kangra , Himachal Pradesh. 20–24
  7. Mishra R, Pandey A, Mishra H, et al (2023) Clinico-epidemiological profile and treatment outcome in adolescents and young patients of rectal cancer attending a tertiary cancer center. J Cancer Res Ther 19:2005–2011. https://doi.org/10.4103/jcrt.jcrt_319_22
  8. Pandey A, Mishra H, Singh PK, Mishra R (2023) Hiccups: An atypical side effect experienced during chemo-radiotherapy in carcinoma nasopharynx. J Cancer Res Ther 19:S977–S979. https://doi.org/10.4103/jcrt.jcrt_318_22
  9. Pandey A, Choudhary S, Verma C, Mani N (2023) Seminoma of testis with isolated bony metastasis at presentation. J Cancer Res Ther 19:484. https://doi.org/10.4103/jcrt.jcrt_1957_21
  10. Pandey A, Mishra H, Mishra R (2022) Role of Radiotherapy in Spinal Cord Compression Due to Extramedullary Hematopoiesis in Thalassemia Intermedia. Neurol India 70:1294–1295. https://doi.org/10.4103/0028-3886.349587
  11. Mishra R, Pandey A, Mishra H, et al (2023) Survival outcome and prognostic factors post inadvertent hysterectomy in carcinoma cervix treated with salvage chemo-radiation. J Cancer Res Clin Oncol 149:12355–12364. https://doi.org/10.1007/s00432-023-05081-7
  12. Thakur V, Prashar P, Thakur A, Bhardwaj B, Sharma H, Pandey A (2023) Bladder Brilliance : Unveiling the Tapestry of Knowledge on Bladder Cancer in District Kangra , Himachal Pradesh. 35–39
  13. Prashar P, Thakur V, Bhardwaj B, Thakur A, Pandey A, Sharma H  (2023) Empowering Kangra : Unveiling the Spectrum of Breast Cancer Awareness and Knowledge in Himachal Pradesh. 45–48
  14. Pandey A, Kumar D, Gupta P, et al (2023) Primary retroperitoneal squamous cell carcinoma: a literature review. J Cancer Res Clin Oncol 149:12507–12512. https://doi.org/10.1007/s00432-023-04969-8

Dr. Siddharth Arora

Dr. Siddharth Arora completed his bachelor’s from the prestigious Sri Devaraj urs Academy Kolar Karnataka. He went on to do a diplomate in the national board in radiation oncology from Yashoda Hospitals Hyderabad. Following he completed his fellowship in Clinical Oncology from Tata medical centre Kolkata. Further at Tata Hospital Sangrur he continued as a senior resident. He has joined Rohilkhand Medical College in the Department of Radiation Oncology.

Professional membership AROI
European counsel of medical oncology
Cleared ESMO examination

Special interests include head and neck cancers, oral cancers, brain tumours, cervical cancer, uterine cancer, prostate cancer, lung cancer, breast cancer, bladder cancer, oesophagal cancer and pancreatic cancer.

Publications

Prioritizing delivery of cancer treatment during a COVID-19 lockdown- the experience of a clinical oncology service in India, JCO Global Oncology 2021

About

Dr Prarabdh Singh is a Consultant Radiation Oncologist & completed his Masters in Radiation Oncology from esteemed Tata Memorial Hospital, Mumbai in 2021.He has completed his 1 year of senior residency from Tata Memorial Hospital itself & additional 2 years in Mahamana Pandit Madan Mohan Malviya Cancer Centre (TMH Branch, Varanasi)

His range of clinical expertise expands from (2D,3D to IMRT/IGRT/VMAT/SRS/SBRT planning), brachytherapy in Gynaecological, Head & Neck & Soft tissue sarcomas.

Currently he is associated with Rohilkhand Cancer institute Bareilly as Assistant Professor.

Experience with technology:

Linear accelerator: TRUEBEAM,6EX, UNIQUE, TOMOTHERAPY, NOVALIS TRILOGY

Telecobalt: THERATRON 780-c/EQUINOX

Brachytherapy: ELEKTA FLEXITRON Cobalt-60 brachytherapy unit

Dr Prarabdh Singh

MBBS, MD (Radiation Oncology)

Our Services

3 Dimensional Conformal Radiation Therapy (3DCRT)

Intensity Modulated Radiation Therapy and Volumetric Modulated Radiation Therapy (IMRT & VMAT)

Stereotactic Radiosurgery & Stereotactic Body Radiation Therapy (SRS & SBRT)

Image Guided Radiation Treatment (IGRT)

Respiratory Gating

Total Skin Electron Radiation Therapy (TSET)

Brachytherapy

True Beam

Deliver precise dosage quickly and give patients their time back—the True Beam® radiotherapy system is built with human needs in mind. Designed to treat cancer wherever it’s found in the body, it’s flexible enough to meet your clinical needs as well.

rohilkhand.jpg12

TrueBeam High-precision cancer treatment

Intuitive

User-centered design makes it easier to perform treatment—and let you focus more energy on your patients..

Innovative

Facilitates innovation and collaboration that results in new treatment options for patients, new opportunities for clinics, and new advances in the fight against cancer.

Integrated

User-centered design makes it easier to perform treatment—and let you focus more energy on your patients.

Enquiry Form